TrialScientific reports2020

Ceritinib in Japanese patients with anaplastic lymphoma kinase (ALK)+ non-small cell lung cancer: interim analysis results of a post-marketing surveillance study.

Hiroyasu Kaneda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.